Mary Clare Walker

1.3k total citations
25 papers, 911 citations indexed

About

Mary Clare Walker is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Mary Clare Walker has authored 25 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Virology and 9 papers in Immunology. Recurrent topics in Mary Clare Walker's work include HIV Research and Treatment (11 papers), Multiple Myeloma Research and Treatments (5 papers) and Immunotherapy and Immune Responses (5 papers). Mary Clare Walker is often cited by papers focused on HIV Research and Treatment (11 papers), Multiple Myeloma Research and Treatments (5 papers) and Immunotherapy and Immune Responses (5 papers). Mary Clare Walker collaborates with scholars based in United States, France and Canada. Mary Clare Walker's co-authors include Patricia Fast, John R. Mascola, Geoffrey J. Gorse, Barney S. Graham, Robert B. Belshe, M. Juliana McElrath, Raphael Dolin, M L Clements, Carl Monder and Donald S. Burke and has published in prestigious journals such as The Journal of Immunology, Applied and Environmental Microbiology and Biochemistry.

In The Last Decade

Mary Clare Walker

24 papers receiving 877 citations

Peers

Mary Clare Walker
James A. Bradac United States
E K Cobb United States
Li‐Hua Ping United States
Russell D. Schmidt United States
Denys Brand France
William M. Hurni United States
Nicole Back Netherlands
Jason B. Dinoso United States
Rebecca L. Dunfee United States
Beatriz Pacheco United States
James A. Bradac United States
Mary Clare Walker
Citations per year, relative to Mary Clare Walker Mary Clare Walker (= 1×) peers James A. Bradac

Countries citing papers authored by Mary Clare Walker

Since Specialization
Citations

This map shows the geographic impact of Mary Clare Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Clare Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Clare Walker more than expected).

Fields of papers citing papers by Mary Clare Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Clare Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Clare Walker. The network helps show where Mary Clare Walker may publish in the future.

Co-authorship network of co-authors of Mary Clare Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Clare Walker. A scholar is included among the top collaborators of Mary Clare Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Clare Walker. Mary Clare Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, Thomas G., Michael C. Keefer, Kent J. Weinhold, et al.. (1999). A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+Cytotoxic T Lymphocyte Responses in Seronegative Volunteers. The Journal of Infectious Diseases. 180(2). 290–298. 134 indexed citations
2.
Gorse, Geoffrey J., Lawrence Corey, Gira Patel, et al.. (1999). HIV-1MN Recombinant Glycoprotein 160 Vaccine-Induced Cellular and Humoral Immunity Boosted by HIV-1MN Recombinant Glycoprotein 120 Vaccine. AIDS Research and Human Retroviruses. 15(2). 115–132. 27 indexed citations
3.
Gorse, Geoffrey J., Thomas J. Matthews, Robert B. Belshe, et al.. (1998). Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. Vaccine. 16(5). 493–506. 20 indexed citations
4.
Zolla‐Pazner, Susan, Carl R. Alving, Robert B. Belshe, et al.. (1997). Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus—Uninfected Recipients of Candidate AIDS Vaccines. The Journal of Infectious Diseases. 175(4). 764–774. 39 indexed citations
5.
Mascola, John R., S W Snyder, O. S. Weislow, et al.. (1996). Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1. The Journal of Infectious Diseases. 173(2). 340–348. 354 indexed citations
6.
Walker, Mary Clare, Patricia Fast, Barney S. Graham, Robert B. Belshe, & Raphael Dolin. (1995). Phase I/II Preventive Vaccine Trials: Conference Summary. AIDS Research and Human Retroviruses. 11(10). 1279–1285. 11 indexed citations
7.
Sheppard, Heather, Sandra H. Bridges, Bonnie J. Mathieson, Mary Clare Walker, & K J Weinhold. (1994). Conference on advances in AIDS vaccine development--1993. Summary: correlates of HIV Immunity Working Group.. PubMed. 10 Suppl 2. S171–6. 3 indexed citations
8.
Mascola, John R., et al.. (1993). Summary Report: Workshop on the Potential Risks of Antibody-Dependent Enhancement in Human HIV Vaccine Trials. AIDS Research and Human Retroviruses. 9(12). 1175–1184. 75 indexed citations
9.
Fast, Patricia & Mary Clare Walker. (1993). Human trials of experimental AIDS vaccines. AIDS. 7. S147–S160. 32 indexed citations
10.
Zolla‐Pazner, Susan, Bonnie J. Mathieson, Mary Clare Walker, & Bruce D. Walker. (1992). Summary: Clinical Immunology Working Group. AIDS Research and Human Retroviruses. 8(8). 1441–1443. 1 indexed citations
11.
Ward, Robyn L., David I. Bernstein, Elizabeth C. Young, et al.. (1989). Effects of Antibody to Rotavirus on Protection of Adults Challenged with a Human Rotavirus. The Journal of Infectious Diseases. 159(1). 79–88. 113 indexed citations
12.
Mandeville, Rosemonde, et al.. (1987). Affinity Purification of a High Molecular Weight Human Breast Cancer-Associated Antigen Identified by the BCD-B4 Monoclonal Antibody. Hybridoma. 6(5). 441–451. 1 indexed citations
13.
Walker, Mary Clare, et al.. (1986). Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.. PubMed. 46(1). 190–7. 1 indexed citations
14.
Walker, Mary Clare, et al.. (1983). Genetic Control of Corticosteroid Side-Chain Isomerase Activity in the Mouse*. Endocrinology. 112(3). 924–930. 8 indexed citations
15.
Walker, Mary Clare & Julia M. Phillips‐Quagliata. (1979). Hybrid resistance to BALB/c plasmacytomas. II. Radiation sensitivity and silica insensitivity of resistance to MPC-11.. PubMed. 122(4). 1544–7. 9 indexed citations
16.
Walker, Mary Clare & Julia M. Phillips‐Quagliata. (1979). Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2.. PubMed. 122(4). 1535–43. 7 indexed citations
17.
Walker, Mary Clare & Julia M. Phillips‐Quagliata. (1979). Hybrid Resistance to BALB/c Plasmacytomas. The Journal of Immunology. 122(4). 1535–1543. 2 indexed citations
18.
O’Brien, William J., Mary Clare Walker, P.L. Fan, & William M. Johnston. (1978). Effect of hydrostatic tensile stress on the growth of Escherichia coli and Bacillus cereus. Applied and Environmental Microbiology. 36(4). 549–551.
19.
Walker, Mary Clare, et al.. (1977). The purification of antimorphine antibodies by affinity chromatography.. Journal of Pharmacology and Experimental Therapeutics. 203(2). 360–364. 2 indexed citations
20.
Monder, Carl & Mary Clare Walker. (1970). Interactions between corticosteroids and histones. Biochemistry. 9(12). 2489–2497. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Bradac Breakdown of academic impact, for papers by E K Cobb Breakdown of academic impact, for papers by Li‐Hua Ping Breakdown of academic impact, for papers by Russell D. Schmidt Breakdown of academic impact, for papers by Denys Brand Breakdown of academic impact, for papers by William M. Hurni Breakdown of academic impact, for papers by Nicole Back Breakdown of academic impact, for papers by Jason B. Dinoso Breakdown of academic impact, for papers by Rebecca L. Dunfee Breakdown of academic impact, for papers by Beatriz Pacheco
Rankless by CCL
2026